What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.06%Above 5Y avg (0.81%)
Annual Rate
CNY 0.11Paid annual
Payout Ratio
28.2%Sustainable
Payback Period
93.9 yr
Last Ex-Dividend
May 27, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.78BCNY
1.03B · vs all stocks (USD)
Updated Nov 22, 2026
Trailing P/E
26.52x
Updated Nov 22, 2026
Revenue (TTM)
1.27BCNY
193.86M · vs all stocks (USD)
Updated Nov 22, 2026
Profit Margin
18.76%
Updated Nov 22, 2026
Beta
0.5900x
vs all stocks
Updated Nov 22, 2026
52-Week Change
-21.70%
vs all stocks
Updated Nov 22, 2026
Market Capitalization
5.78BCNY
1.03B · vs all stocks (USD)
Updated Nov 22, 2026
Enterprise Value
6.25BCNY
1.14B · vs all stocks (USD)
Updated Nov 22, 2026
Trailing P/E
26.52x
Updated Nov 22, 2026
Forward P/E
13.10x
Updated Nov 22, 2026
Price to Sales (TTM)
4.55x
Updated Nov 22, 2026
Price to Book (MRQ)
1.60x
Updated Nov 22, 2026
Enterprise to Revenue
4.92x
Updated Nov 22, 2026
Enterprise to EBITDA
12.57x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 18.27×.Updated Nov 22, 2026
Gross Margin
42.84%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 45.6%.Updated Nov 22, 2026
Profit Margin
18.76%
Updated Nov 22, 2026
Operating Margin
23.82%
Updated Nov 22, 2026
Return on Assets (TTM)
3.19%
Updated Nov 22, 2026
Return on Equity (TTM)
6.79%
Updated Nov 22, 2026
Revenue (TTM)
1.27BCNY
193.86M · vs all stocks (USD)
Updated Nov 22, 2026
Revenue per Share (TTM)
2.35CNYUpdated Nov 22, 2026
Quarterly Revenue Growth
-7.60%
Updated Nov 22, 2026
Gross Profit (TTM)
579.76MCNY
96.10M · vs all stocks (USD)
Updated Nov 22, 2026
EBITDA (TTM)
342.37MCNY
51.29M · vs all stocks (USD)
Updated Nov 22, 2026
Net Income (TTM)
238.52MCNY
41.23M · vs all stocks (USD)
Updated Nov 22, 2026
Quarterly Earnings Growth (YoY)
-50.60%
Updated Nov 22, 2026
Operating Cash Flow (TTM)
444.98MCNY
59.11M · vs all stocks (USD)
Updated Nov 22, 2026
Levered Free Cash Flow (TTM)
-249.26MCNY
-11.36M · vs all stocks (USD)
Updated Nov 22, 2026
Trailing Annual Dividend Rate
0.1130CNYUpdated Nov 22, 2026
Trailing Annual Dividend Yield
1.06%
vs all stocks
Updated Nov 22, 2026
5-Year Average Dividend Yield
0.81%
vs all stocks
Updated Nov 22, 2026
Payout Ratio
28.25%
Updated Nov 22, 2026
Minority Interest (Equity)
-10.13KCNYFY2025 · Dec 31, 2025
Revenue
1.24BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
549.06MCNYFY2025 · Dec 31, 2025
Gross Profit
688.34MCNYFY2025 · Dec 31, 2025
Operating Income
383.03MCNY
57.38M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
352.50MCNYFY2025 · Dec 31, 2025
Income Tax Expense
47.64MCNYFY2025 · Dec 31, 2025
Net Income
304.86MCNYFY2025 · Dec 31, 2025
EBIT
384.97MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
571.39MCNYFY2025 · Dec 31, 2025
Research & Development
65.46MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
149.90MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
25.40MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
8.24MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
32.47MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.5600CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.5100CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
544.40MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
544.40MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
304.86MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
6.32KCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
293.81MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-67.21MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
924.32MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
304.86MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
31.94MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-132.19MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
89.20MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-361.02MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-1.75BCNYFY2025 · Dec 31, 2025
Sale of Investments
1.50BCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-610.16MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
1.13BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-1.15BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-92.15MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-90.00MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-208.25MCNYFY2025 · Dec 31, 2025
Shares Outstanding
544.82MSharesUpdated Nov 22, 2026
Float Shares
359.89MSharesUpdated Nov 22, 2026
% Held by Insiders
34.03%
vs all stocks
Updated Nov 22, 2026
% Held by Institutions
9.16%
vs all stocks
Updated Nov 22, 2026
Total Cash (MRQ)
1.38BCNY
204.89M · vs all stocks (USD)
Updated Nov 22, 2026
Total Cash per Share (MRQ)
2.54CNYUpdated Nov 22, 2026
Total Debt (MRQ)
1.86BCNY
275.38M · vs all stocks (USD)
Updated Nov 22, 2026
Total Debt to Equity (MRQ)
0.5140x
Updated Nov 22, 2026
Current Ratio (MRQ)
2.06x
Updated Nov 22, 2026
Book Value per Share (MRQ)
6.63CNYUpdated Nov 22, 2026
Total Assets
5.78BCNY
866.11M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
2.42BCNYFY2025 · Dec 31, 2025
Total Liabilities
2.29BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
3.37BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
1.33BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
958.12MCNYFY2025 · Dec 31, 2025
Cash
924.32MCNYFY2025 · Dec 31, 2025
Cash Equivalents
108.11MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
1.03BCNYFY2025 · Dec 31, 2025
Other Short-term Investments
301.22MCNYFY2025 · Dec 31, 2025
Accounts Receivable
224.30MCNYFY2025 · Dec 31, 2025
Inventory
750.08MCNYFY2025 · Dec 31, 2025
Accounts Payable
328.88MCNYFY2025 · Dec 31, 2025
Short-term Debt
491.43MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
2.04MCNYFY2025 · Dec 31, 2025
Long-term Debt
1.26BCNYFY2025 · Dec 31, 2025
Common Stock (Book)
543.47MCNYFY2025 · Dec 31, 2025
Retained Earnings
2.50BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
3.49BCNY
522.67M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
10.60CNYUpdated Nov 22, 2026
52-Week High
23.44CNYUpdated Nov 22, 2026
52-Week Change
-21.70%
vs all stocks
Updated Nov 22, 2026
Beta
0.5900x
vs all stocks
Updated Nov 22, 2026
50-Day MA
13.62CNYUpdated Nov 22, 2026
200-Day MA
14.57CNYUpdated Nov 22, 2026
Avg 10-Day Volume
12.31MSharesUpdated Nov 22, 2026
Avg 30-Day Volume
15.67MSharesUpdated Nov 22, 2026
Diluted EPS (TTM)
0.4000CNYUpdated Nov 22, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.